About Aclarion
Aclarion is a company based in Broomfield (United States) founded in 2008. Aclarion has raised $3.26 million across 4 funding rounds. The company has 6 employees as of December 31, 2024. Aclarion offers products and services including NOCISCAN. Aclarion operates in a competitive market with competitors including AIdoc, AI Medical Service, eCential Robotics, Lantheus and Vista.ai, among others.
- Headquarter Broomfield, United States
- Employees 6 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aclarion, Inc.
-
Annual Revenue
$45.72 K (USD)-39.36as on Dec 31, 2024
-
Net Profit
-$6.99 M (USD)-42.38as on Dec 31, 2024
-
EBITDA
-$5.32 M (USD)-12.87as on Dec 31, 2024
-
Total Equity Funding
$3.26 M (USD)
in 4 rounds
-
Latest Funding Round
$20 M (USD), Post-IPO
Feb 04, 2025
-
Investors
Not available
-
Employee Count
6
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aclarion
Aclarion is a publicly listed company on the NASDAQ with ticker symbol ACON in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aclarion
Aclarion offers a comprehensive portfolio of products and services, including NOCISCAN.
Uses MR Spectroscopy to identify painful spinal discs noninvasively.
People of Aclarion
Unlock access to complete
Unlock access to complete
Funding Insights of Aclarion
Aclarion has successfully raised a total of $3.26M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Aclarion
Investment portfolio details for Aclarion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aclarion
Detailed financials for Aclarion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aclarion Comparisons
Peer comparison for Aclarion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aclarion
Aclarion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, AI Medical Service, eCential Robotics, Lantheus and Vista.ai, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostic imaging agents and targeted therapeutics
|
|
| Locked | Locked | Locked |
AI-guided software is utilized to automate MRI exams for clinicians.
|
|
| Locked | Locked | Locked |
Provider of AI-based skin cancer monitoring and detecting device for patients and doctors
|
Detailed competitors of Aclarion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aclarion
Complete news archive for Aclarion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aclarion
Aclarion was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Aclarion is headquartered in Broomfield, United States. It is registered at Broomfield, Colorado, United States.
Brent Ness is the current CEO of Aclarion.
Aclarion is a funded company, having raised a total of $3.26M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Aclarion is 6.
Annual revenue of Aclarion is $45.72K as on Dec 31, 2024.
Founded in 2008 and based in Broomfield, United States, Aclarion operates in the healthcare technology sector. Software is developed to support radiology image analysis through a SaaS model. Raw medical imaging data is processed into metabolic biomarkers, with features enabled for MRI diagnosis and diagnostic analysis. Assistance is offered to providers for enhanced imaging and diagnostic workflows.
Aclarion's top competitors include AIdoc, eCential Robotics and Vista.ai.
Aclarion offers NOCISCAN.
Yes, Aclarion is publicly traded on NASDAQ under the ticker symbol ACON.
The ticker symbol of Aclarion is ACON on NASDAQ.